To assess the role of Homoeopathic medicine Phosphorus 200C in treating nervous affection among patients with increased glucose level.

Effectiveness of Phosphorus 200C for the Management of Diabetic polyneuropathy in patients with Type 2 Diabetes Mellitus: An Experimental Study - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/069917

Enrollment

Registered

2024-07-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Intervention1: Phosphorus 200C: Phosphorus 200C will be prescribed based on the totality. One dose will be administered every 15 days orally based on improvement of patient. Patient is asked for regul

Eligibility

Inclusion criteria

Inclusion criteria: Diabetic mellitus with peripheral neuropathic manifestation. HBA1C- more than 6.5 Age group more than 35 years. Both sexes. MNSI score more than 4 on questionnaire and more than 2 on examination.

Exclusion criteria

Exclusion criteria: Pregnant women. Patient with non-diabetic neuropathy. Patient with any other neurological condition. MNSI Score below 4 on the questionnaire.

Design outcomes

Primary

Measure	Time frame
Patient HBA1C level and MNSI Score before administration of medicine.Timepoint: 6 Months	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr N V Sugathan

Sarada Krishna Homoeopathic Medical College

drnvsugathan@gmail.com9443558786

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026